106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\adrac-publishes-its-latest-bulletin.html <-- CSMWM /public_html/2004/12 adrac-publishes-its-latest-bulletin.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\atomoxetine-strattera-and-liver.html <-- CSMWM /public_html/2004/12 atomoxetine-strattera-and-liver.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\cardiovascular-safety-of-celecoxib.html <-- CSMWM /public_html/2004/12 cardiovascular-safety-of-celecoxib.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\cardiovascular-toxicity-of-valdecoxib.html <-- CSMWM /public_html/2004/12 cardiovascular-toxicity-of-valdecoxib.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\csm-expert-working-group-on-safety-of.html <-- CSMWM /public_html/2004/12 csm-expert-working-group-on-safety-of.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\emea-press-release-on-review-of-cox-2.html <-- CSMWM /public_html/2004/12 emea-press-release-on-review-of-cox-2.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\further-advice-on-cox-2-inhibitors.html <-- CSMWM /public_html/2004/12 further-advice-on-cox-2-inhibitors.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\interaction-between.html <-- CSMWM /public_html/2004/12 interaction-between.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\mhra-warns-of-illegal-importation-of.html <-- CSMWM /public_html/2004/12 mhra-warns-of-illegal-importation-of.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\naproxen-and-cardiovascular-events.html <-- CSMWM /public_html/2004/12 naproxen-and-cardiovascular-events.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\our-latest-bulletin-is-published.html <-- CSMWM /public_html/2004/12 our-latest-bulletin-is-published.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\rosuvastatin-crestor.html <-- CSMWM /public_html/2004/12 rosuvastatin-crestor.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\updated-safety-information-on-disodium.html <-- CSMWM /public_html/2004/12 updated-safety-information-on-disodium.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\use-of-celecoxib-to-treat-familial.html <-- CSMWM /public_html/2004/12 use-of-celecoxib-to-treat-familial.html
106.07.27 23:28 B D:\My documents\My Webs\csmwm\2004\12\valdecoxib-bextra-skin-reactions.html <-- CSMWM /public_html/2004/12 valdecoxib-bextra-skin-reactions.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\adrac-publishes-its-latest-bulletin.html --> www.adr.org.uk /public_html/2004/12 adrac-publishes-its-latest-bulletin.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\atomoxetine-strattera-and-liver.html --> www.adr.org.uk /public_html/2004/12 atomoxetine-strattera-and-liver.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\cardiovascular-safety-of-celecoxib.html --> www.adr.org.uk /public_html/2004/12 cardiovascular-safety-of-celecoxib.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\cardiovascular-toxicity-of-valdecoxib.html --> www.adr.org.uk /public_html/2004/12 cardiovascular-toxicity-of-valdecoxib.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\csm-expert-working-group-on-safety-of.html --> www.adr.org.uk /public_html/2004/12 csm-expert-working-group-on-safety-of.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\emea-press-release-on-review-of-cox-2.html --> www.adr.org.uk /public_html/2004/12 emea-press-release-on-review-of-cox-2.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\further-advice-on-cox-2-inhibitors.html --> www.adr.org.uk /public_html/2004/12 further-advice-on-cox-2-inhibitors.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\interaction-between.html --> www.adr.org.uk /public_html/2004/12 interaction-between.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\mhra-warns-of-illegal-importation-of.html --> www.adr.org.uk /public_html/2004/12 mhra-warns-of-illegal-importation-of.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\naproxen-and-cardiovascular-events.html --> www.adr.org.uk /public_html/2004/12 naproxen-and-cardiovascular-events.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\our-latest-bulletin-is-published.html --> www.adr.org.uk /public_html/2004/12 our-latest-bulletin-is-published.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\rosuvastatin-crestor.html --> www.adr.org.uk /public_html/2004/12 rosuvastatin-crestor.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\updated-safety-information-on-disodium.html --> www.adr.org.uk /public_html/2004/12 updated-safety-information-on-disodium.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\use-of-celecoxib-to-treat-familial.html --> www.adr.org.uk /public_html/2004/12 use-of-celecoxib-to-treat-familial.html
106.08.04 09:57 B D:\My documents\My Webs\csmwm\2004\12\valdecoxib-bextra-skin-reactions.html --> www.adr.org.uk /public_html/2004/12 valdecoxib-bextra-skin-reactions.html